Computational study of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus

References

• Alexpandi, R., De Mesquita, J. F., Pandian, S. K., & Ravi, A. V. (2020). Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: An in silico analysis. Frontiers in Microbiology, 11, 1796. https://doi.org/10.3389/fmicb.2020.01796
   Google Scholar
• Arts, E. J., & Hazuda, D. J. (2012). HIV-1 antiretroviral drug therapy. Cold Spring Harbor Perspectives in Medicine, 2 (4), a007161. https://doi.org/10.1101/cshperspect.a007161
   PubMed Web of Science ®Google Scholar
• Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir. Res, 178, 104787. https://doi.org/10.1016/j.antiviral.2020.104787
   PubMed Web of Science ®Google Scholar
• Cao, Y.-c., Deng, Q.-x., & Dai, S.-x. (2020). Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Travel Medicine and Infectious Disease., 35, 101647. https://doi.org/10.1016/j.tmaid.2020.101647
   PubMed Web of Science ®Google Scholar
• Chang, Y., Tung, Y., Lee, K., Chen, T., Hsiao, Y., Chang, H., Hsieh, T., Su, C., Wang, S., Yu, J., Shih, S., Lin, Y., Lin, Y., Tu, Y. E., Tung, C., & Chen, C. (2020). Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking. Preprints. https://www.preprints.org/manuscript/202002.0242/v1.
   Google Scholar
• Choy, K.-T., Wong, A. Y.-L., Kaewpreedee, P., Sia, S. F., Chen, D., Hui, K. P. Y., Chu, D. K. W., Chan, M. C. W., Cheung, P. P.-H., Huang, X., Peiris, M., & Yen, H.-L. (2020). Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Research, 178, 104786. https://doi.org/10.1016/j.antiviral.2020.104786
   PubMed Web of Science ®Google Scholar
• Dallakyan, S., & Olson, A. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology (Clifton, NJ), 1263, 243–250. https://doi.org/10.1007/978-1-4939-2269-7_19
   PubMedGoogle Scholar
• Eastman, R. T., Roth, J. S., Brimacombe, K. R., Simeonov, A., Shen, M., Patnaik, S., & Hall, M. D. (2020). Remdesivir: A review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Central Science., 6 (5), 672–683. https://doi.org/10.1021/acscentsci.0c00489
   PubMed Web of Science ®Google Scholar
• El Zowalaty, M. E., & Järhult, J. D. J. O. H. (2020). From SARS to COVID-19: A previously unknown SARS-CoV-2 virus of pandemic potential infecting humans–Call for a One Health approach. One Health, 9, 100124. https://doi.org/10.1016/j.onehlt.2020.100124
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A. (2020). Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences, 253, 117592. https://doi.org/10.1016/j.lfs.2020.117592
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49 (21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., & Wang, T. (2020). Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science, 368 (6492), 779–782. https://doi.org/10.1126/science.abb7498
   PubMed Web of Science ®Google Scholar
• Godoy, A. S., Lima, G. M., Oliveira, K. I., Torres, N. U., Maluf, F. V., Guido, R. V., & Oliva, G. (2017). Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase. Nature Communications, 8, 14764.
   PubMedGoogle Scholar
• Gordon, C. J., Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2020a). The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. Journal of Biological Chemistry, 295 (15), 4773–4779. https://doi.org/10.1074/jbc.AC120.013056
   PubMed Web of Science ®Google Scholar
• Gordon, C. J., Tchesnokov, E. P., Woolner, E., Perry, J. K., Feng, J. Y., Porter, D. P., & Götte, M. (2020b). Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. Journal of Biological Chemistry, 295(20), 6785–6797. https://doi.org/10.1074/jbc.RA120.013679
   PubMed Web of Science ®Google Scholar
• Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47 (7), 1750–1759. https://doi.org/10.1021/jm030644s
   PubMed Web of Science ®Google Scholar
• Kaur, J., Tsvetkova, Y., Arroub, K., Sahnoun, S., Kiessling, F., & Mathur, S. (2017). Synthesis, characterization, and relaxation studies of Gd-DO3A conjugate of chlorambucil as a potential theranostic agent. Chemical Biology and Drug Design, 89(2), 269–276. https://doi.org/10.1111/cbdd.12827
   PubMed Web of Science ®Google Scholar
• Koulgi, S., Jani, V., Uppuladinne, M. V. N., Sonavane, U., & Joshi, R. (2020). Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2. RSC Advances, 10(45), 26792–26803. https://doi.org/10.1039/D0RA04743K
   PubMed Web of Science ®Google Scholar
• Kumar, S., Sharma, P. P., Shankar, U., Kumar, D., Joshi, S. K., Pena, L., & Durvasula, R. (2020). Discovery of New hydroxyethylamine analogs against 3CLpro protein target of SARS-CoV-2: Molecular docking, molecular dynamics simulation, and structure–activity relationship studies. Journal of Chemical Information and Modeling, 60(12), 5754–5770. https://doi.org/10.1021/acs.jcim.0c00326
   PubMed Web of Science ®Google Scholar
• Li, G., & De Clercq, E. (2020). Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews Drug Discovery, 19(3), 149–150. https://doi.org/10.1038/d41573-020-00016-0
   PubMed Web of Science ®Google Scholar
• Liu, C., Zhou, Q., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., Smoot, J., Gregg, A. C., Daniels, A. D., Jervey, S., & Albaiu, D. (2020a). Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Central Science, 6(3), 315–331. https://doi.org/10.1021/acscentsci.0c00272
   PubMed Web of Science ®Google Scholar
• Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020b). Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery, 6(1), 16. doi: 0.1038/s41421-020-0156-0. https://doi.org/10.1038/s41421-020-0156-0
   PubMed Web of Science ®Google Scholar
• Mackenzie, J. S., & Smith, D. W. (2020). COVID-19: A novel zoonotic disease caused by a coronavirus from China: What we know and what we don’t. Microbiology Australia, 41(1), 45–50. https://doi.org/10.1071/MA20013
   Web of Science ®Google Scholar
• Morris, A. L., MacArthur, M. W., Hutchinson, E. G., & Thornton, J. M. (1992). Stereochemical quality of protein structure coordinates. Proteins, 12(4), 345–364. https://doi.org/10.1002/prot.340120407
   PubMed Web of Science ®Google Scholar
• Nittari, G., Pallotta, G., Amenta, F., & Tayebati, S. K. (2020). Current pharmacological treatments for SARS-COV-2: A narrative review. European Journal of Pharmacology, 882, 173328. https://doi.org/10.1016/j.ejphar.2020.173328
   PubMed Web of Science ®Google Scholar
• Rathi, A. K., Syed, R., Shin, H.-S., & Patel, R. V. (2016). Piperazine derivatives for therapeutic use: A patent review (2010–present). Expert Opinion on Therapeutic Patents, 26 (7), 777–797. https://doi.org/10.1080/13543776.2016.1189902
   PubMed Web of Science ®Google Scholar
• Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA, 323(18), 1824–1836. https://doi.org/10.1001/jama.2020.6019
   PubMed Web of Science ®Google Scholar
• Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., Bannister, R., Park, Y., Babusis, D., Clarke, M. O., Mackman, R. L., Spahn, J. E., Palmiotti, C. A., Siegel, D., Ray, A. S., … Baric, R. S. (2017). Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Science Translational Medicine, 9(396), eaal3653. https://doi.org/10.1126/scitranslmed.aal3653
   PubMed Web of Science ®Google Scholar
• Shirota, Y., Luo, H., Qin, W., Kaneko, S., Yamashita, T., Kobayashi, K., & Murakami, S. (2002). Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. Journal of Biological Chemistry, 277(13), 11149–11155. https://doi.org/10.1074/jbc.M111392200
   PubMed Web of Science ®Google Scholar
• Siegel, D., Hui, H. C., Doerffler, E., Clarke, M. O., Chun, K., Zhang, L., Neville, S., Carra, E., Lew, W., Ross, B., Wang, Q., Wolfe, L., Jordan, R., Soloveva, V., Knox, J., Perry, J., Perron, M., Stray, K. M., Barauskas, O., … Mackman, R. L. (2017). Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of ebola and emerging viruses. Journal of Medicinal Chemistry, 60(5), 1648–1661. https://doi.org/10.1021/acs.jmedchem.6b01594
   PubMed Web of Science ®Google Scholar
• Subissi, L., Posthuma, C. C., Collet, A., Zevenhoven-Dobbe, J. C., Gorbalenya, A. E., Decroly, E., Snijder, E. J., Canard, B., & Imbert, I. (2014). One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proceedings of the National Academy of Sciences of the United States of America, 111(37), E3900–E9. https://doi.org/10.1073/pnas.1323705111
   PubMed Web of Science ®Google Scholar
• Sumit, K., Poonam, & Brijesh, R. (2020). Coronavirus disease COVID-19: A new threat to public health. Current Topics in Medicinal Chemistry, 20(8), 599–600. https://doi.org/10.2174/1568026620999200305144319.
   PubMed Web of Science ®Google Scholar
• Tchesnokov, E. P., Feng, J Y., Porter, D. P., & Götte, M. (2019). Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses, 11(4), 326. https://doi.org/10.3390/v11040326
   PubMed Web of Science ®Google Scholar
• Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., Chen, H., Mubareka, S., Gubbay, J. B., & Chan, W. C. W. (2020). Diagnosing COVID-19: The disease and tools for detection. ACS Na, 14(4), 3822–3835. https://doi.org/10.1021/acsnano.0c02624
   PubMed Web of Science ®Google Scholar
• Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/10.1038/s41422-020-0282-0
   PubMed Web of Science ®Google Scholar
• World Health Organisation. (2020). Coronavirus disease (COVID-2019) Weekly epidemiological update on COVID-19 - 30 March 2021. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-31-march-2021.
   Google Scholar
• Yamamoto, N., Matsuyama, S., Hoshino, T., & Yamamoto, N. (2020). Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro. bioRxiv. https://doi.org/10.1101/2020.04.06.
   Google Scholar
• Yin, W., Mao, C., Luan, X., Shen, D.-D., Shen, Q., Su, H., Wang, X., Zhou, F., Zhao, W., Gao, M., Chang, S., Xie, Y. C., Tian, G., Jiang, H. W., Tao, S. C., Shen, J., Jiang, Y., Jiang, H., Xu, Y., Zhang, S., … Xu, H. E. (2020). Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science, 368(6498), 1499–1504. https://doi.org/10.1126/science.abc1560
   PubMed Web of Science ®Google Scholar
• Zhang, L., Zhang, D., Wang, X., Yuan, C., Li, Y., Jia, X., ... & Huang, X. (2021). 1′-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication. Physical Chemistry Chemical Physics, 23(10), 5852–5863. https://doi.org/10.1039/D0CP05948J
   Google Scholar
• Zhang, L., & Zhou, R. (2020). Binding mechanism of remdesivir to SARS-CoV-2 RNA dependent RNA polymerase. Preprints. https://www.preprints.org/manuscript/202003.0267/v1.
   Google Scholar